Tag: J&J

J&J exec talks digital health during the COVID-19 pandemic

Over the course of the COVID-19 pandemic, the healthcare industry has undergone a digital transformation. Now, as vaccines become more readily available, and as cases continue to fall, the question on many healthcare leaders’ minds is: How can that innovation continue in a post-pandemic world? In a HIMSS21 Global Conference Digital Session set to air on Tuesday,

J&J ‘very confident’ in vaccine, eyes quick resolution

Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday. “We remain very confident and very hopeful that the benefit-risk profile will play out,” J&J Chief Financial Officer Joseph Wolk told CNBC. The comments came ahead of a decision

US J&J Covid vaccine pause continues after experts defer vote

A pause on all US vaccinations with the Johnson & Johnson COVID shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder. The Centers for Disease Control and Prevention (CDC) convened a meeting a day

US to distribute 4 million J&J COVID vaccines by Tuesday

Four million doses of the latest COVID-19 vaccine to get US approval will be delivered across the country as early as Tuesday, a senior administration official said. The United States on Saturday authorized Johnson & Johnson’s COVID vaccine for emergency use, boosting President Joe Biden’s plan to battle the outbreak that has killed more than